Jenny Liu is a patent agent in the Boston office of Wilson Sonsini Goodrich & Rosati, where she is a member of the patents and innovations practice. She has technical knowledge across a variety of fields, including organic, polymer, bioconjugate, and peptide chemistry. Her practice focuses on patent prosecution and intellectual property matters for life sciences clients.
Prior to joining the firm, Jenny held positions as a medicinal, synthetic, and process chemist at several biotech start-ups and a specialty CRO and worked primarily in the small molecule and bioconjugates space.
Jenny earned her Ph.D. in chemistry from Massachusetts Institute of Technology, in the lab of Professor Jeremiah Johnson. Her research focused on the design and synthesis of polymer-drug conjugates using ring opening metathesis polymerization. Jenny has co-authored several scientific publications and a book chapter. Additionally, she has presented at American Chemical Society national meetings and is a co-inventor on five patent applications.
Jenny Liu is a patent agent in the Boston office of Wilson Sonsini Goodrich & Rosati, where she is a member of the patents and innovations practice. She has technical knowledge across a variety of fields, including organic, polymer, bioconjugate, and peptide chemistry. Her practice focuses on patent prosecution and intellectual property matters for life sciences clients.
Prior to joining the firm, Jenny held positions as a medicinal, synthetic, and process chemist at several biotech start-ups and a specialty CRO and worked primarily in the small molecule and bioconjugates space.
Jenny earned her Ph.D. in chemistry from Massachusetts Institute of Technology, in the lab of Professor Jeremiah Johnson. Her research focused on the design and synthesis of polymer-drug conjugates using ring opening metathesis polymerization. Jenny has co-authored several scientific publications and a book chapter. Additionally, she has presented at American Chemical Society national meetings and is a co-inventor on five patent applications.
- Ph.D., Chemistry, Massachusetts Institute of Technology, 2017
Recipient, National Sciences and Engineering Research Council of Canada Postgraduate Scholarship; Recipient, MIT Department of Chemistry Award for Outstanding Teaching
- B.S., Chemistry, McGill University, 2011
With First Class Honours, Dean's Honour List
- Member, American Chemical Society
- Member, American Intellectual Property Law Association
- U.S. Patent and Trademark Office
- Ph.D., Chemistry, Massachusetts Institute of Technology, 2017
Recipient, National Sciences and Engineering Research Council of Canada Postgraduate Scholarship; Recipient, MIT Department of Chemistry Award for Outstanding Teaching
- B.S., Chemistry, McGill University, 2011
With First Class Honours, Dean's Honour List
- Member, American Chemical Society
- Member, American Intellectual Property Law Association
- U.S. Patent and Trademark Office
Select Publications
- Co-author, "Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant Variants," 67(21) Journal of Medicinal Chemistry 19623-19667, 2024
- Co-author, "Reduction of Liver Fibrosis by Rationally Designed Macromolecular Telmisartan Prodrugs," 2 Nature Biomedical Engineering 822-830, 2018
- Co-author, "Chapter 2.1.5 Alkene Metathesis Based Polymerization," 2 Science of Synthesis: N-Heterocyclic Carbenes in Catalytic Organic Synthesis 99-126, 2017
- Co-author, "A Convergent Synthetic Platform for Single-Nanoparticle Combination Cancer Therapy: Ratiometric Loading and Controlled Release of Cisplatin, Doxorubicin, and Camptothecin," 136(16) Journal of the American Chemical Society 5896-5899, 2014
- Co-author, “‘Brush-First’ Method for the Parallel Synthesis of Photocleavable, Nitroxide-Labeled Poly(ethylene glycol) Star Polymers," 134(39) Journal of the American Chemical Society 16337-16344, 2012
Select Publications
- Co-author, "Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant Variants," 67(21) Journal of Medicinal Chemistry 19623-19667, 2024
- Co-author, "Reduction of Liver Fibrosis by Rationally Designed Macromolecular Telmisartan Prodrugs," 2 Nature Biomedical Engineering 822-830, 2018
- Co-author, "Chapter 2.1.5 Alkene Metathesis Based Polymerization," 2 Science of Synthesis: N-Heterocyclic Carbenes in Catalytic Organic Synthesis 99-126, 2017
- Co-author, "A Convergent Synthetic Platform for Single-Nanoparticle Combination Cancer Therapy: Ratiometric Loading and Controlled Release of Cisplatin, Doxorubicin, and Camptothecin," 136(16) Journal of the American Chemical Society 5896-5899, 2014
- Co-author, “‘Brush-First’ Method for the Parallel Synthesis of Photocleavable, Nitroxide-Labeled Poly(ethylene glycol) Star Polymers," 134(39) Journal of the American Chemical Society 16337-16344, 2012
- Privacy Policy
- Terms of Use
- Accessibility